Add Company
Join Now

OncoSenX Revenue and Competitors

License our Company Data API

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OncoSenX's estimated annual revenue is currently $1.7M per year.(i)
  • OncoSenX's estimated revenue per employee is $155,000

Employee Data

  • OncoSenX has 11 Employees.(i)
  • OncoSenX grew their employee count by -27% last year.

OncoSenX's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Science OfficerReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
ChairmanReveal Email/Phone
5
President Corporate DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is OncoSenX?

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA. The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M11N/AN/A
#2
$0.4M11-31%$11M
#3
$1M11N/AN/A
#4
$1M11N/AN/A
#5
$3.5M11N/AN/A